Understanding idiopathic intracranial hypertension: mechanisms, management, and future directions

KA Markey, SP Mollan, RH Jensen… - The Lancet …, 2016 - thelancet.com
Idiopathic intracranial hypertension is a disorder characterised by raised intracranial
pressure that predominantly affects young, obese women. Pathogenesis has not been fully …

Idiopathic intracranial hypertension: consensus guidelines on management

SP Mollan, B Davies, NC Silver, S Shaw… - Journal of Neurology …, 2018 - jnnp.bmj.com
The aim was to capture interdisciplinary expertise from a large group of clinicians, reflecting
practice from across the UK and further, to inform subsequent development of a national …

Evolving evidence in adult idiopathic intracranial hypertension: pathophysiology and management

SP Mollan, F Ali, G Hassan-Smith, H Botfield… - Journal of Neurology …, 2016 - jnnp.bmj.com
Idiopathic intracranial hypertension (IIH) is a rare but important disease associated with
significant morbidity. There is an expected rise in prevalence in line with the escalating …

2018 Update of the EULAR recommendations for the management of large vessel vasculitis

B Hellmich, A Agueda, S Monti, F Buttgereit… - Annals of the …, 2020 - ard.bmj.com
Background Since the publication of the European League Against Rheumatism (EULAR)
recommendations for the management of large vessel vasculitis (LVV) in 2009, several …

[HTML][HTML] The expanding burden of idiopathic intracranial hypertension

SP Mollan, M Aguiar, F Evison, E Frew, AJ Sinclair - Eye, 2019 - nature.com
Objective To quantify the hospital burden and health economic impact of idiopathic
intracranial hypertension. Methods Hospital Episode Statistics (HES) national data was …

Effectiveness of bariatric surgery vs community weight management intervention for the treatment of idiopathic intracranial hypertension: a randomized clinical trial

SP Mollan, JL Mitchell, RS Ottridge, M Aguiar… - JAMA …, 2021 - jamanetwork.com
Importance Idiopathic intracranial hypertension (IIH) causes headaches, vision loss, and
reduced quality of life. Sustained weight loss among patients with IIH is necessary to modify …

[HTML][HTML] European headache federation guideline on idiopathic intracranial hypertension

J Hoffmann, SP Mollan, K Paemeleire, C Lampl… - The journal of headache …, 2018 - Springer
Abstract Background Idiopathic Intracranial Hypertension (IIH) is characterized by an
elevation of intracranial pressure (ICP no identifiable cause. The aetiology remains largely …

Treat-to-target recommendations in giant cell arteritis and polymyalgia rheumatica

C Dejaco, A Kerschbaumer, D Aletaha… - Annals of the …, 2024 - ard.bmj.com
Objectives To develop treat-to-target (T2T) recommendations in giant cell arteritis (GCA) and
polymyalgia rheumatica (PMR). Methods A systematic literature review was conducted to …

[HTML][HTML] A unique androgen excess signature in idiopathic intracranial hypertension is linked to cerebrospinal fluid dynamics

MW O'Reilly, CSJ Westgate, C Hornby, H Botfield… - JCI insight, 2019 - ncbi.nlm.nih.gov
Idiopathic intracranial hypertension (IIH) is a condition of unknown etiology, characterized by
elevated intracranial pressure frequently manifesting with chronic headaches and visual …

A practical approach to, diagnosis, assessment and management of idiopathic intracranial hypertension

SP Mollan, KA Markey, JD Benzimra, A Jacks… - Practical …, 2014 - pn.bmj.com
Adult patients who present with papilloedema and symptoms of raised intracranial pressure
need urgent multidisciplinary assessment including neuroimaging, to exclude life …